Introduction
DNA methylation plays an important role in regulating cellular differentiation and development (1) . As aberrant DNA methylation of specific loci is also linked to pathologic processes like carcinogenesis (for review, see Reference 2) , the analysis of DNA methylation-based biomarkers represents a promising method for tumor diagnosis. The use of such biomarkers in body fluids (e.g., blood or urine) of cancer patients might allow for early detection of the disease (3) (4) (5) (6) . However, these samples usually contain high concentrations of background DNA from normal cells and only a small portion of DNA from the tumor. Therefore, one major challenge for the application of methylation biomarkers in diagnostic routine is the sensitive detection of single copies of methylated DNA in a high amount of unmethylated background DNA. Several methods exist that are applicable for DNA methylation analysis. However, most of these techniques do not allow for sensitive detection.
As of now, PCR analysis after bisulfite conversion is the method of choice when sensitive detection is desired (7) . Bisulfite treatment of the template DNA leads to deamination of unmethylated cytosines to uracil, leaving only methylated cytosines unaltered and thereby transforming epigenetic information into sequence information. Methylation-specific PCR (MSP), HeavyMethyl, and Headloop PCR are methods that allow for the detection of single copies of methylated DNA. In MSP, primers bind specifically to bisulfiteconverted methylated or unmethylated DNA, leading to specific amplification (8) . Advantages of this technique are its high relative sensitivity, ease of design, and low complexity of the reaction. However, for certain loci, primer design can be challenging for reaching acceptable specificity. HeavyMethyl technology is based on amplification of bisulfite-treated DNA using methylation-unspecific primers in combination with methylationspecific blocking oligonucleotides (9) . In HeavyMethyl PCR, the high number of different oligonucleotides per assay can be challenging with respect to assay design. However, the possibility to adapt blocking conditions leads to increased assay flexibility and allows for the selective amplification of even such loci where specific MSP is hardly possible. In Headloop PCR, the amplification of specific sequences after bisulfite treatment is suppressed through an extension at the 5′ end of the primers (10): After synthesis of the strand including the extension, the 5′ end can internally bind if the amplicon contains the respective recognition sequence, which prevents further amplification. This technique is highly sensitive and specific, but primer design and the optimization of PCR conditions for specific loop formation are challenging. Methods that allow for sensitive detectionespecially at loci where MSP and HeavyMethyl assay designs are difficult-would offer a significant improvement for DNA methylation analysis.
In this paper, a new technique for the sensitive and specific amplification of methylated DNA is presented, which is based on the digestion of bisulfiteconverted, unmethylated DNA during each PCR cycle via the restriction endonuclease Tsp509I. Tsp509I, which specifically cuts at AATT sites, was previously used to analyze the efficiency of DNA bisulfite conversion A novel method for sensitive and specific detection of DNA methylation biomarkers based on DNA restriction during PCR cycling DNA methylation is an important epigenetic mechanism involved in fundamental biological processes such as development, imprinting, and carcinogenesis. For these reasons, DNA methylation represents a valuable source for cancer biomarkers. Methods for the sensitive and specific detection of methylated DNA are a prerequisite for the implementation of DNA biomarkers into clinical routine when early detection based on the analysis of body fluids is desired. Here, a novel technique is presented for the detection of DNA methylation biomarkers, based on real-time PCR of bisulfite-treated template with enzymatic digestion of background DNA during amplification using the heatstable enzyme Tsp509I. An assay for the lung cancer methylation biomarker BARHL2 was used to show clinical and analytical performance of the method in comparison with methylation-specific PCR technology. Both technologies showed comparable performance when analyzing technical DNA mixtures and bronchial lavage samples from 75 patients suspected of having lung cancer. The results demonstrate that the approach is useful for sensitive and specific detection of a few copies of methylated DNA in samples with a high background of unmethylated DNA, such as in clinical samples from body fluids. (11) . The specific cleavage of unmethylated template is based on the presence of CpG dinucleotides in the sequence context AATCG or AACCG within the region of interest. After bisulfite conversion, these sequences will either be converted to AATCG (CpG methylated) or AATTG (CpG unmethylated). Therefore, only unmethylated CpG sites in the described sequence contexts result in a recognition site after bisulfite treatment, enabling the digestion of the template. Due to its optimal incubation temperature of 65°C, heat stability, and high activity under different buffering conditions, it is possible to use Tsp509I directly in the PCR reaction. During each PCR cycle, the enzymatic activity leads to cleavage of PCR products arising from unmethylated bisulfite-converted template, whereas methylated sequences remain unaffected.
In general, DNA restriction is a common technique for methylation analysis. Methylation-sensitive endonucleases have previously been used to digest non-bisulfite treated unmethylated template prior to PCR (12, 13) . The major disadvantage of this pre-PCR restriction is that even minor remnants of non-digested DNA will be amplified, leading to false-positive results. However, such by-products are inevitable, as restriction enzymes do not reach complete digestion, especially when the DNA is fragmented or partially single-stranded, as is expected in body fluids. Accordingly, the sensitive and specific detection of methylated DNA is limited. In combined bisulfite restriction analysis (COBRA), bisulfite-treated DNA is subjected to a single restriction step after PCR (14) . In COBRA, all DNA is amplified, without a preferred (biased) amplification of methylated DNA. Thus, samples that originally contained only traces of methylated DNA will also only contain minor portions of originally methylated DNA in the PCR product. These small amounts cannot easily be detected via enzymatic restriction. The new Tsp509I assay overcomes these limitations via digestion of unmethylated background during PCR cycling. This leads to highly sensitive and specific detection of methylated DNA as shown in comparative analysis with MSP on predefined DNA mixtures. The high performance of the new technique was confirmed on patient sample material in a case-control study with bronchial lavage samples from 75 patients examined for suspected lung cancer using the lung cancer DNA methylation biomarker BARHL2 (Bar-like homeobox) (15, 16) . • 
Material and methods
One half of this mixture was transferred to a centrifugal device and centrifuged for 10 min at 5000× g. The flow-through was discarded and the procedure was repeated with the second half of the bisulfite reaction mixture. The membrane was washed with 400 µL 0.2 M NaOH and three times with 400 µL water. The centrifugal device was centrifuged for 12 min at 5000× g during each washing step. For DNA elution, 100 µL pre-warmed water (50°C) was added to the sample reservoir and incubated for 10 min while shaking at 1000 rpm and 50°C.
The DNA concentration was determined by UV spectrophotometry using a Nanodrop ND-1000 spectral photometer (Nanodrop Technologies, Wilmington, DE, USA). Converted sperm DNA and converted universal methylated DNA were mixed to produce samples with defined amounts of methylated target and unmethylated background DNA.
Patient samples
Specimens were collected at the Charité-University Hospital Berlin with appropriate written consent under approval of local ethics committees. Bronchial lavage samples were obtained from 75 patients (39 benign lung disease, 36 cancers). All patients donating bronchial lavage samples were examined for suspected lung cancer. Samples were collected by aspiration with a flexible bronchoscope after injecting 10-20 mL isotonic saline solution. Samples were centrifuged according to clinical standard procedures and the pellets stored at -80°C. The diagnosis of bronchial carcinoma was confirmed by one or more of the following approaches: computed tomographic scan, histology or cytology, biopsy or surgery specimen; and lavage samples were taken prior to starting any cancer-specific treatment. For this study, the control group consisted of those patients who underwent workup for suspected lung cancer in the same time period and at the same clinics, but who did not show any evidence of malignant lung disease and had a minimum lung cancerfree survival of 12 months.
The frozen pellets were thawed at room temperature and resuspended in 500 µL PBS buffer and 30 µL 1,4-Dithiothreitol [1.5% (w/v)]. Samples were incubated for 30 min at 37°C and 1000 rpm in a thermomixer and finally centrifuged for 12 min at 3200× g. DNA extraction was carried out using the QIAamp Micro Kit. Bisulfite conversion of extracted sample DNA was performed using the EpiTect Kit. Bisulfite-converted DNA from bronchial lavage samples (0.25 µL) was applied to the real-time PCR.
Real-time PCR PCR was carried out using the QuantiTect Multiplex Kit (Qiagen, Hilden, Gemany) with 0. 
Results and discussion
In this study, a novel method for highly sensitive and specific detection of DNA methylation biomarkers that utilizes cleavage of PCR product from bisulfiteconverted unmethylated DNA during PCR cycling by the restriction endonu- clease Tsp509I is introduced. To determine the analytical performance of the Tsp509I assay, defined samples of methylated and unmethylated DNA were analyzed. To test the impact of Tsp509I on amplification, PCR efficiencies were compared in the presence and absence of the restriction enzyme ( Figure 1) . Presence of the enzyme did not impair the PCR since bisulfite converted methylated template is amplified with the same efficiency, irrespective of the presence of Tsp509I. The PCR efficiencies for the amplification of bisulfite-converted methylated DNA were 1.92 [95% confidence interval (CI): 1.88-1.96] without enzyme and 1.96 (95% CI: 1.92-2.10) with enzyme ( Figure 1A ). PCR amplification of bisulfite-converted DNA from sperm is completely inhibited in the presence of the enzyme, while the PCR efficiency without enzyme is unaffected [efficiency 1.94 (95% CI: 1.91-1.97), Figure 1B ]. Melting curve analysis confirmed the specific amplification of bisulfite DNA from methylated and unmethylated DNA ( Figure  1B ). Unmethylated BARHL2 amplicon derived from sperm DNA showed a T m of 74.6°C, while methylated amplicon melted at 76.2°C, due to the additional C nucleotides after bisulfite conversion ( Figure  1C ). To determine the analytical performance in complex sample material, predefined mixtures of DNA from sperm and methylated DNA were used for analysis (Figure 2 ). When Tsp509I was added to the reaction, the methylated target with DNA concentrations as little as 10 pg (approximately three genome copies) was amplified in the presence of ≤5000-fold excess of unmethylated background DNA from sperm. The specific amplification of methylated DNA was confirmed by melting curve analysis ( Figure 2B ). In addition, an MSP assay was tested on the same mixtures. In this study, the restriction enzyme Tsp509I was shown to be useful for highly sensitive and specific detection of methylated DNA in a background of unmethylated DNA. The advantage of Tsp509I-based cleavage during PCR is that the enzyme's heat stability allows for the digestion of undesired amplicons as they appear in each PCR cycle. The result is a strong bias for the amplification of the target template, bisulfite-converted methylated DNA. Although the temperatures and conditions used during PCR may prevent Tsp509I from being at its maximal activity, the results shown here confirm that use of this restriction enzyme during PCR leads to an effective suppression of amplification of background (previously unmethylated) DNA.
As the formation of a Tsp509I recognition site upon bisulfite treatment is a prerequisite for this technique, the method is only applicable to fragments which contain at least one AATCG or AACCG site. On the other hand, the bisulfite-converted DNA must not contain the sequences AATT, AACC, AACT, and AATC outside the CpG context. This would preclude analysis due to a complete cleavage of all DNA specimens, unless these sites are located in the primer binding site and can be eliminated using respective mismatch primers. The described BARLH2 assay contained two AATC sites outside the CpG context. These sites are located in the primer binding sites and were eliminated using a primer with two mismatches.
The sequences required for the Tsp509I assay as described above are related to an analysis using the bisulfiteconverted leading strand as template. When using the bisulfite-converted lagging strand to design the assay, sequences containing the stretches, CGATT or CGGTT can also be analyzed. In this case, the sequences GGTT, AGTT, AATT, and GATT outside the CpG context would preclude the analysis since these sequences would result in an AATT recognition site after bisulfite conversion. It is difficult to predict at how many sites within the human genome a Tsp509I assay design might be possible. However, assays were also designed and tested for the DNA methylation biomarkers EV X2 and EN2. In a small study comprising 23 tissue samples (11 cancers/12 controls), both assays were well suited to distinguish between normal and cancer tissue (data not shown). The principle of sensitive detection using heat-stable restriction enzymes and digestion during every PCR cycle can easily be adapted to the sensitive detection of unmethylated biomarkers (e.g., the usage of the heat-stable restriction enzyme BstU I allows for the detection of unmethylated CGCG sites).
In conclusion, we have developed an inexpensive and time-saving procedure for sensitive and specific amplification of methylated DNA that complements existing techniques quite well. Furthermore, a combination of MSP, HM, or Headloop PCR with Tsp509I cleavage could be a suitable tool for methylation analysis.
